Are aclidinium and aclidinium/formoterol used according to their approved indication in Europe? Results of a multicountry drug utilization postauthorization safety study

Elena Rivero-Ferrer; Anna Julia Witzleb; Morten Olesen; Estel Plana; Jaume Aguado; Nuria Saigi-Morgui; Annalisa Rubino; Sami Z. Daoud; Alejhandra Lei; Susana Perez-Gutthann; Tania Schink; Nina S. Kristiansen; Anton Pottegard; Cristina Rebordosa

Are aclidinium and aclidinium/formoterol used according to their approved indication in Europe? Results of a multicountry drug utilization postauthorization safety study

Elena Rivero-Ferrer, Anna Julia Witzleb, Morten Olesen, Estel Plana, Jaume Aguado, Nuria Saigi-Morgui, Annalisa Rubino, Sami Z. Daoud, Alejhandra Lei, Susana Perez-Gutthann, Tania Schink, Nina S. Kristiansen, Anton Pottegard, Cristina Rebordosa

Clinical Pharmacology, Pharmacy and Environmental Medicine

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	3865
Journal	Pharmacoepidemiology and Drug Safety
Volume	29
Issue number	Suppl. 3
Pages (from-to)	175
Number of pages	1
ISSN	1053-8569
Publication status	Published - 1. Oct 2020
Event	36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management - Duration: 16. Sept 2020 → 17. Sept 2020

Conference

Conference	36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Period	16/09/2020 → 17/09/2020

Cite this

Rivero-Ferrer, E., Witzleb, A. J., Olesen, M., Plana, E., Aguado, J., Saigi-Morgui, N., Rubino, A., Daoud, S. Z., Lei, A., Perez-Gutthann, S., Schink, T., Kristiansen, N. S., Pottegard, A., & Rebordosa, C. (2020). Are aclidinium and aclidinium/formoterol used according to their approved indication in Europe? Results of a multicountry drug utilization postauthorization safety study. Pharmacoepidemiology and Drug Safety, 29(Suppl. 3), 175. Article 3865.

@article{1310108886044034988b239ea76762fb,

title = "Are aclidinium and aclidinium/formoterol used according to their approved indication in Europe? Results of a multicountry drug utilization postauthorization safety study",

author = "Elena Rivero-Ferrer and Witzleb, {Anna Julia} and Morten Olesen and Estel Plana and Jaume Aguado and Nuria Saigi-Morgui and Annalisa Rubino and Daoud, {Sami Z.} and Alejhandra Lei and Susana Perez-Gutthann and Tania Schink and Kristiansen, {Nina S.} and Anton Pottegard and Cristina Rebordosa",

year = "2020",

month = oct,

day = "1",

language = "English",

volume = "29",

pages = "175",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "Wiley",

number = "Suppl. 3",

note = "36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management ; Conference date: 16-09-2020 Through 17-09-2020",

}

Rivero-Ferrer, E, Witzleb, AJ, Olesen, M, Plana, E, Aguado, J, Saigi-Morgui, N, Rubino, A, Daoud, SZ, Lei, A, Perez-Gutthann, S, Schink, T, Kristiansen, NS, Pottegard, A & Rebordosa, C 2020, 'Are aclidinium and aclidinium/formoterol used according to their approved indication in Europe? Results of a multicountry drug utilization postauthorization safety study', Pharmacoepidemiology and Drug Safety, vol. 29, no. Suppl. 3, 3865, pp. 175.

Are aclidinium and aclidinium/formoterol used according to their approved indication in Europe? Results of a multicountry drug utilization postauthorization safety study. / Rivero-Ferrer, Elena; Witzleb, Anna Julia; Olesen, Morten et al.
In: Pharmacoepidemiology and Drug Safety, Vol. 29, No. Suppl. 3, 3865, 01.10.2020, p. 175.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Are aclidinium and aclidinium/formoterol used according to their approved indication in Europe? Results of a multicountry drug utilization postauthorization safety study

AU - Rivero-Ferrer, Elena

AU - Witzleb, Anna Julia

AU - Olesen, Morten

AU - Plana, Estel

AU - Aguado, Jaume

AU - Saigi-Morgui, Nuria

AU - Rubino, Annalisa

AU - Daoud, Sami Z.

AU - Lei, Alejhandra

AU - Perez-Gutthann, Susana

AU - Schink, Tania

AU - Kristiansen, Nina S.

AU - Pottegard, Anton

AU - Rebordosa, Cristina

PY - 2020/10/1

Y1 - 2020/10/1

M3 - Conference abstract in journal

SN - 1053-8569

VL - 29

SP - 175

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - Suppl. 3

M1 - 3865

T2 - 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management

Y2 - 16 September 2020 through 17 September 2020

ER -